Karakousis, Giorgos C.
,
Gimotty, Phyllis A.
Leong, Stanley P.
Pockaj, Barbara A.
White, Richard L.
O’Donoghue, Cristina
Sinnamon, Andrew J.
Bartlett, Edmund K.
Dueck, Amylou C.
Gould Rothberg, Bonnie E.
Messina, Jane L.
Vetto, John T.
Sondak, Vernon K.
Schneebaum, Schlomo
Kashani-Sabet, Mohammed
Han, Dale
Faries, Mark B.
Zager, Jonathan S.
Funding for this research was provided by:
National Institutes of Health (P50-CA174523--biostatistical support through NIH M)
Article History
Received: 25 August 2018
First Online: 12 November 2018
Conflicts of interest
: Vernon K. Sondak has served on the Advisory Boards of Merck, Genentech/Roche, Bristol-Myers Squibb, and Novartis; and on the Data Safety Monitoring Boards of Bristol-Myers Squibb, Array, Novartis, Polynoma, and Pfizer. Mohammed Kashani-Sabet holds stock or other interests in Melanoma Diagnostics, Inc. (DNARx); has received honoraria from Cepheid; and has received research funding from Merck. Giorgos C. Karakousis, Phyllis A. Gimotty, Stanley P. Leong, Barbara A. Pockaj, Richard L. White, Cristina O’Donoghue, Andrew J. Sinnamon, Edmund K. Bartlett, Amylou C. Dueck, Bonnie E. Gould Rothberg, Jane L. Messina, John T. Vetto, Schlomo Schneebaum, Dale Han, Mark B. Faries, and Jonathan S. Zager have no conflict of interest to declare.